Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17): a randomized, open-label, multicenter, phase II trial

Metastatic breast cancer refractory to anthracycline and taxanes often shows rapid progression. The development of effective and tolerable combination regimens for these patients is needed. This phase II trial investigated the efficacy of pemetrexed plus vinorelbine in patients with metastatic breast cancer.

Source: European Journal of Cancer - November 20, 2023 Category: Cancer & Oncology Authors: Dae-Won Lee, Kyung Hae Jung, Kyung-Hun Lee, Yeon Hee Park, Keun Seok Lee, Joohyuk Sohn, Hee Kyung Ahn, Jae Ho Jeong, Su-Jin Koh, Jee Hyun Kim, Han Jo Kim, Kyoung Eun Lee, Hee-Jun Kim, Yae-Won Yang, Kyong Hwa Park, Jieun Lee, Hye Sung Won, Tae-Yong Kim, Se Tags: Original Research Source Type: research